Cancer Research in Medicinal Chemistry

The term "cancer" refers to a group of diseases that include irregular cell growth with the latent spread to other parts of the body. As each cancer consists of a various cell types highly effective at developing confrontation to both drug and radiation therapy, it is a particularly difficult disease to treat. The challenge for the field of medicinal chemistry is to design drugs capable of selectively targeting cancer cells while evading multidrug resistance pathways. Using recent observations into the unique attributes of cancer cells, Medicinal Chemistry is pursuing anti-tumor agents of high specificity to help design appropriately targeted, selective chemotherapeutics. Current programs involve a various array of anti-cancer targets, such as lipid and protein kinases, microtubules, topoisomerases, hypoxia inducible factors, bromodomains and histone acetyltransferases.

    Related Conference of Cancer Research in Medicinal Chemistry

    August 28-30, 2018

    10th World Congress on Neuropharmacology

    Paris, France

    Cancer Research in Medicinal Chemistry Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in